Loncar China BioPharma ETF (CHNA) |
| 13.53 -0.01 (-0.07%) 10-17 15:51 |
| Open: | 14.3 |
| High: | 14.3 |
| Low: | 13.53 |
| Volume: | 9 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | NASDAQ Global Market |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
| sell | buy | |||
| Resistance 2: | |
| Resistance 1: | |
| Pivot price: | |
| Support 1: | |
| Support 2: | |
| 52w High: | 22.89 |
| 52w Low: | 9.76966 |
The fund's advisor endeavors to allocate nearly all of its assets to the specific securities and depositary receipts comprising its benchmark index. This index is crafted to reflect the performance of a modified equal-weighted collection of Chinese companies, each playing a direct role in the expansion of China's pharmaceutical and biotechnology sectors.
Financials
| EPS | |
| Book Value | |
| PEG Ratio | |
| Gross Profit |
| Profit Margin (%) | |
| Operating Margin (%) | |
| Return on Assets (ttm) | |
| Return on Equity (ttm) |
Company news
Wed, 22 Mar 2023
Healthcare Stocks List: Top Healthcare Companies & ETFs - Bullish Bears
Tue, 22 Nov 2022
The Nasdaq Golden Dragon is scorching November; China-themed ETFs are doing even better - Stockhead
Sat, 24 Oct 2026
Sat, 24 Oct 2026
Sat, 24 Oct 2026
Sat, 24 Oct 2026
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
